0001437749-24-020851.txt : 20240620 0001437749-24-020851.hdr.sgml : 20240620 20240620180753 ACCESSION NUMBER: 0001437749-24-020851 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240617 FILED AS OF DATE: 20240620 DATE AS OF CHANGE: 20240620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lonial Sagar CENTRAL INDEX KEY: 0001816609 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 241057751 MAIL ADDRESS: STREET 1: C/O TG THERAPEUTICS, INC. STREET 2: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 rdgdoc.xml FORM 4 X0508 4 2024-06-17 0001001316 TG THERAPEUTICS, INC. TGTX 0001816609 Lonial Sagar 3020 CARRINGTON MILL BLVD, SUITE 475 MORRISVILLE NC 27560 1 0 Common Stock 2024-06-17 4 S 0 9585 16.39 D 99293 D Common Stock 2024-06-19 4 A 0 22250 0 A 121543 D Common Stock 2024-06-20 4 S 0 16348 16.87 D 105195 D These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations. Includes shares of restricted Common Stock, which vest over various time periods. Reflects a grant of restricted shares that will vest on June 14, 2025. /s/ Sagar Lonial 2024-06-20